Severe COVID-19 found to be associated with disrupted intestinal Peyer’s patches

NewsGuard 100/100 Score

A team of scientists from the UK has recently demonstrated that severe coronavirus disease 2019 (COVID-19) is associated with pronounced changes in the ileal Peyer’s Patches, which could be responsible for the suppression of intestinal immune responses and subsequent disruption of microbiota homeostasis in the gastrointestinal (GI) tract.

Study: Disrupted Peyer

Study: Disrupted Peyer's patch microanatomy in COVID-19 including germinal centre atrophy independent of local virus. Image Credit: Jose Luis Calvo/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

The study is currently available on the bioRxiv* preprint server, whilst the article undergoes peer review

Background

In viral infections, presence of viruses in the GI tract is known to support long-lived antibody responses that are vital for inhibiting viral propagation. An absence of such response has been found to associate with persistent disease. In about 12% of COVID-19 patients, GI symptoms including diarrhea and vomiting have been observed, indicating the propagation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the GI tract epithelial cells.

In the GI tract, immune responses originate in the lymphoid tissues that produce activated B and T cells. The clusters of gut-associated lymphoid tissues in the terminal ileum are called Peyer’s patches, which contain antigen-specific germinal centers. Antibodies secreted in response to germinal centers play vital roles in regulating the gut microbiota and maintaining homeostasis.

In the current study, the scientists have analyzed GI tract samples collected from deceased COVID-19 patients to localize SARS-CoV-2 and quantify viral RNA. In addition, they have conducted immunohistochemistry and imaging mass cytometry to analyze structural and functional characteristics of ileal Peyer’s patches.        

Important observations

The localization and quantification of SARS-CoV-2 were conducted using samples from theesophagus, stomach, duodenum, ileum, colon, lungs, and spleen. The findings revealed that in severe infection, SARS-CoV-2 is localized throughout the GI tract, with the highest localization in the epithelium and subepithelial lamina propria. However, no presence of the virus was observed in the lymphoid tissues.

Structural and functional characterization of Peyer’s patches

The characterization of ileum Peyer’s patches was conducted by double staining the receptors expressed by B and T cells on the lymphoid tissues. In addition, the germinal center was stained. The findings revealed that compared to control tissues, the ileum Payer’s patches isolated from COVID-19 patients have significantly reduced germinal centers irrespective of the levels of viral RNA.

The immunohistochemistry and imaging mass cytometry analysis was conducted on cells specifically isolated from the lymphoid tissues in the Peyer’s patches. The findings revealed that in COVID-19 patients, the structure of Peyer’s patches is disrupted, and the zonation of B and T cells is lost. In addition, a reduction in the expression of a germinal center-associated transcription factor BCL6 was observed in B and T cells. This transcription factor is required for the development of germinal center B cells and follicular helper T cells.

The analysis of cellular interactions in Peyer’s patches revealed a higher fraction of macrophages in follicles of COVID-19 samples compared to that in control follicles. In addition, a significantly reduced cellular density was observed in the lymphoid tissues obtained from COVID-19 patients.

A significantly reduced interaction between B cell and T cell was observed in the ileal follicles in Peyer’s patches of COVID-19 patients. In addition, a significantly lower level of memory B cells was observed in Peyer’s patches of COVID-19 patients.   

Study significance

The study demonstrates significantly altered structure and cellularity of Peyer’s patches in deceased COVID-19 patients. The depletion in germinal centers, reduction in B cell – T cell interaction, and lower cellular density observed in ileal Peyer’s patches indicate that the gut immune system is disrupted and cannot induce sufficient immune responses. Collectively, these factors could lead to significant dysbiosis.  

Interestingly, changes in Peyer’s patches are not associated with the levels of viral RNA. This indicates that the changes are due to systemic inflammation and not due to the virus.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 9 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2023, May 09). Severe COVID-19 found to be associated with disrupted intestinal Peyer’s patches. News-Medical. Retrieved on April 24, 2024 from https://www.news-medical.net/news/20211221/Severe-COVID-19-found-to-be-associated-with-disrupted-intestinal-Peyere28099s-patches.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Severe COVID-19 found to be associated with disrupted intestinal Peyer’s patches". News-Medical. 24 April 2024. <https://www.news-medical.net/news/20211221/Severe-COVID-19-found-to-be-associated-with-disrupted-intestinal-Peyere28099s-patches.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Severe COVID-19 found to be associated with disrupted intestinal Peyer’s patches". News-Medical. https://www.news-medical.net/news/20211221/Severe-COVID-19-found-to-be-associated-with-disrupted-intestinal-Peyere28099s-patches.aspx. (accessed April 24, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2023. Severe COVID-19 found to be associated with disrupted intestinal Peyer’s patches. News-Medical, viewed 24 April 2024, https://www.news-medical.net/news/20211221/Severe-COVID-19-found-to-be-associated-with-disrupted-intestinal-Peyere28099s-patches.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook